Literature DB >> 2040920

Autoimmune enteropathy and nephropathy with circulating anti-epithelial cell antibodies.

R B Colletti1, A P Guillot, S Rosen, A K Bhan, C D Hobson, A B Collins, G J Russell, H S Winter.   

Abstract

We describe a child with circulating anti-epithelial cell antibodies, autoimmune enteropathy with intestinal villous atrophy, and membranous glomerulonephritis. The patient had persistent diarrhea at 6 months of age, and a small bowel biopsy showed active enteritis, villous atrophy, and crypt hyperplasia. When the patient was, 10 months of age, nephrotic syndrome developed because of membranous glomerulonephritis. Results of tests for circulating immune complexes were negative. Indirect immunofluorescence studies revealed a circulating antibody directed against renal epithelial cells. Circulating antibodies directed against normal small intestine epithelial cells were also detected by the immunoperoxidase technique. Western blot and immunoprecipitation identified a 55-kd antigen, in both small bowel and kidney, that reacted with an antibody in the patient's serum. High-dose prednisone therapy induced a clinical remission, resolution of the small bowel injury, and diminished serum anti-epithelial cell antibodies; after dose reduction, clinical relapse occurred with villous atrophy and reappearance of anti-epithelial cell antibodies. When the patient was 45 months of age, persistent diarrhea recurred despite intravenous administration of corticosteroids, cyclosporine, and total parenteral nutrition. Autoantibodies to a 55-kd epithelial cell protein are temporally related to the development of enteropathy and nephropathy. Study of similar patients is needed to determine the role of such antibodies in this disorder.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2040920     DOI: 10.1016/s0022-3476(05)82195-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

Review 1.  Nongranulomatous chronic idiopathic enterocolitis: a primary histologically defined disease.

Authors:  K H Soergel
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

Review 2.  An approach to duodenal biopsies.

Authors:  S Serra; P A Jani
Journal:  J Clin Pathol       Date:  2006-05-05       Impact factor: 3.411

Review 3.  Autoimmune enteropathy: a review and update of clinical management.

Authors:  Nicole M Gentile; Joseph A Murray; Darrell S Pardi
Journal:  Curr Gastroenterol Rep       Date:  2012-10

Review 4.  Autoimmune Enteropathy: An Updated Review with Special Focus on Stem Cell Transplant Therapy.

Authors:  Zunirah Ahmed; Aamer Imdad; James A Connelly; Sari Acra
Journal:  Dig Dis Sci       Date:  2018-11-10       Impact factor: 3.199

5.  Clinical quiz. A 1.5 year-old boy with autoimmune enteropathy.

Authors:  O Koskimies; T Klemola; E Savilahti
Journal:  Pediatr Nephrol       Date:  1995-02       Impact factor: 3.714

6.  Mechanisms of villous atrophy in autoimmune enteropathy and coeliac disease.

Authors:  R Ciccocioppo; S D'Alo; A Di Sabatino; R Parroni; M Rossi; C Doglioni; M G Cifone; G R Corazza
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

7.  X-Linked syndrome of polyendocrinopathy, immune dysfunction, and diarrhea maps to Xp11.23-Xq13.3.

Authors:  C L Bennett; R Yoshioka; H Kiyosawa; D F Barker; P R Fain; A O Shigeoka; P F Chance
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

8.  A 75-kD autoantigen recognized by sera from patients with X-linked autoimmune enteropathy associated with nephropathy.

Authors:  I Kobayashi; K Imamura; M Yamada; M Okano; A Yara; S Ikema; N Ishikawa
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

9.  A Japanese family of X-linked auto-immune enteropathy with haemolytic anaemia and polyendocrinopathy.

Authors:  N Satake; M Nakanishi; M Okano; K Tomizawa; A Ishizaka; K Kojima; M Onodera; T Ariga; A Satake; Y Sakiyama
Journal:  Eur J Pediatr       Date:  1993-04       Impact factor: 3.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.